Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Portobello SpA

    MCap

    EUR12m

    Last close

    EUR2.39

    ▲ 0.15 (6.70%)

    Mendus

    MCap

    SEK403m

    Last close

    SEK7.65

    ▲ −0.34 (−4.26%)

    The Metals Company

    MCap

    USD613m

    Last close

    USD1.73

    ▲ −0.05 (−2.81%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Creo Medical (AIM: CREO)

Last close As at 04/02/2025

GBP0.18

▲ −0.25 (−1.37%)

Market capitalisation

GBP76m

UK-based Creo Medical focuses on the development and commercialisation of minimally invasive electrosurgical devices. Its six products in the flagship CROMA platform have all been CE marked, with five cleared by the FDA. Acquired in 2020, Albyn Medical provides Creo with profitable products and a direct salesforce in Europe.

Latest Insights

View More

Healthcare | Flash note

Creo Medical — Consumables business divested in strategic move

Healthcare | Flash note

Creo Medical — Intuitive deal expansion is a notable milestone

Healthcare | edison tv

Creo Medical – executive interview with Craig Gulliford, CEO

Healthcare | Update

Creo Medical — Setting the stage for pivotal growth
creo05
Visit Website

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Analyst, Healthcare

Key Management

  • Craig Gulliford

    CEO

  • David Woods

    Chief commercial officer

  • Richard Rees

    CFO

edison tv

Healthcare

Creo Medical – executive interview with Craig Gulliford, CEO

Update

Healthcare

Creo Medical — Growth momentum with core strength
creo05

Flash note

Healthcare

Creo Medical — CE extension nearly doubles addressable GI
creo05

Flash note

Healthcare

Creo Medical — NICE to review Speedboat Inject

Flash note

Healthcare

Creo Medical — New NHS client win for CROMA technology
creo05

Update

Healthcare

Creo Medical — Entering phase of accelerating growth inflection

Flash note

Healthcare

Creo Medical — Albyn Medical stake acquired as wholly owned
creo05

Flash note

Healthcare

Creo Medical — Observational studies to expand capabilities
creo05

Flash note

Healthcare

Creo Medical — Around £30m raised in 48 hours to back growth plans

Outlook

Healthcare

Creo Medical — Progressing on all fronts
creo05

Flash note

Healthcare

Creo Medical — A rewarding FY22 for core technology arsenal

Flash note

Healthcare

Creo Medical — Second robotics deal signed

Update

Healthcare

Creo Medical — Building momentum in 2022

Flash note

Healthcare

Creo Medical — Continued growth momentum in H122

Flash note

Healthcare

Creo Medical — Solid FY21 followed by robotics deal with Intuitive

Flash note

Healthcare

Creo Medical — Positive Q122 trading update

QuickView

Creo — Unlocking the potential of rare cannabinoids

edison tv

Healthcare

Edison Open House – Creo Medical

Initiation

Healthcare

Creo Medical — Providing energy for endoscopic surgery